0000905148-23-001472.txt : 20231116
0000905148-23-001472.hdr.sgml : 20231116
20231116194111
ACCESSION NUMBER: 0000905148-23-001472
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231114
FILED AS OF DATE: 20231116
DATE AS OF CHANGE: 20231116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blume-Jensen Peter
CENTRAL INDEX KEY: 0001950499
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41551
FILM NUMBER: 231416096
MAIL ADDRESS:
STREET 1: C/O ACRIVON THERAPEUTICS, INC.
STREET 2: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc.
CENTRAL INDEX KEY: 0001781174
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825125532
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-207-8979
MAIL ADDRESS:
STREET 1: 480 ARSENAL WAY, SUITE 100
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
form4.xml
X0508
4
2023-11-14
0001781174
Acrivon Therapeutics, Inc.
ACRV
0001950499
Blume-Jensen Peter
C/O ACRIVON THERAPEUTICS, INC.
480 ARSENAL WAY, SUITE 100
WATERTOWN
MA
02472
true
true
President and CEO
false
Common Stock
2023-11-14
4
F
0
239023
5.08
D
2658673
D
Common Stock
318805
I
See footnote
Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
These securities are held by co-founder and EVP, Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
2023-11-16